In his current roles as senior vice president of finance and chief financial officer of Impax Laboratories, Mr. Reasons’ responsibilities span accounting, financial planning and analysis, business development and investor relations, and corporate communications. Before joining Impax in 2012, Mr. Reasons held positions of increasing responsibility at Cephalon, Inc., where he successfully navigated the acquisition by Teva Pharmaceutical Industries Ltd. for eight billion dollars. He previously served in a number of financial leadership roles at E.I. du Pont de Nemours and Company and PricewaterhouseCoopers LLP, ranging from corporate accounting, external reporting and audit, and business advisory services.
Mr. Reasons earned a bachelor’s degree in accounting from Pennsylvania State University and an MBA from Widener University. He is a certified public accountant.